Protein Tyrosine Kinase/RTK
-
BA9006 RET-IN-7Summary: RET-IN-7 shows potent kinase inhibition in vitro. - BA9005 PyrazoloadenineSummary: Pyrazoloadenine is a potent lung cancer oncoprotein inhibitor.
- BA9003 BT44Summary: BT44 is a selective activator.
- BA9001 NSC194598Summary: NSC194598 is a p53 DNA binding inhibitor that inhibits p53 sequence-specific DNA binding in vitro and in vivo at values of 180 nM and 2-40 μM, respectively.
- BA8996 BT-13Summary: BT-13 is a potent, selective agonist (acting independently of GDNF ligands).
- BA8989 ZeteletinibSummary: Zeteletinib (BOS-172738; DS-5010) is an orally effective, selective kinase inhibitor with nanomolar potency against and >300-fold selectivity for VEGFR2.
- BA8984 SoquelitinibSummary: Soquelitinib (CPI-818) is a highly selective covalent inhibitor.
- BA8943 PP58Summary: Pyrido[2,3-d]pyrimidine compounds.
- BA8843 CTA056Summary: CTA056 is an (IL-2 inducible T cell kinase) inhibitor.
- BA8842 RSH-7Summary: RSH-7 is a potent inhibitor.